Document Report Card
Basic Information
ID: ALA4630905
Title: Data for DCP probe GSK789
Authors: SGC Frankfurt
Abstract: SGC Frankfurt donated chemical probe project: GSK789 was donated by GlaxoSmithKline. Website: https://www.sgc-ffm.uni-frankfurt.de/#!specificprobeoverview/GSK789. Control: GSK791. References: 1. Watson, Robert J., Paul Bamborough, Heather Barnett, Chun-Wa Chung, Rob Davis, Laurie Gordon, Paola Grandi, Massimo Petretich, Alex Phillipou, Rab K. Prinjha, Inmaculada Rioja, Peter Soden, Thilo Werner, and Emmanuel H. Demont. 2020. ‘GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins’. Journal of Medicinal Chemistry 63(17):9045–69. doi: 10.1021/acs.jmedchem.0c00614. PMID: 32691589. 2. Gilan, Omer, Inmaculada Rioja, Kathy Knezevic, Matthew J. Bell, Miriam M. Yeung, Nicola R. Harker, Enid Y. N. Lam, Chun-Wa Chung, Paul Bamborough, Massimo Petretich, Marjeta Urh, Stephen J. Atkinson, Anna K. Bassil, Emma J. Roberts, Dane Vassiliadis, Marian L. Burr, Alex G. S. Preston, Christopher Wellaway, Thilo Werner, James R. Gray, Anne-Marie Michon, Thomas Gobbetti, Vinod Kumar, Peter E. Soden, Andrea Haynes, Johanna Vappiani, David F. Tough, Simon Taylor, Sarah-Jane Dawson, Marcus Bantscheff, Matthew Lindon, Gerard Drewes, Emmanuel H. Demont, Danette L. Daniels, Paola Grandi, Rab K. Prinjha, and Mark A. Dawson. 2020. ‘Selective Targeting of BD1 and BD2 of the BET Proteins in Cancer and Immunoinflammation’. Science (New York, N.Y.) 368(6489):387–94. PMID: 32193360.